📰 Including Anaphylaxis News
Including Anaphylaxis News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Including Anaphylaxis. Real-time updates on events, politics, business and more.
July 16, 2024
The arrest at the capitol. Police say a man with a gun in his car and paperwork on eal. Eal claims about the saying members of Congress Want to bring guns onto the floor and have threatened other members. And the newly sworn in congresswoman and the videos. What she said to a survivor of eai abohe las vegas massacre. Tonight, the deadly leak at a plant. At least six workers killed. Workers say there were clouds of chemicals. Employees immediately falling unconscious. The major storm system slamm...
May 1, 2024
New data for TEZSPIRE and BREZTRI demonstrate AstraZeneca’s innovation and commitment to transform care in COPD ...
April 11, 2024
Five new launches reinforce Baxter’s focus on differentiated products and enhance the company’s Pharmaceuticals portfolio in critical therapeutic areas Products feature ready-to-use...
November 16, 2023
/PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that five new presentations related to Peyronies disease, or PD, and XIAFLEX® (collagenase...
September 20, 2023
The FDA's announcement requesting further study represents a step back in the process of 'neffy' becoming the first needle-free nasal spray epinephrine alternative.
June 6, 2023
Via the PhilRx Patient Access Platform, patients can now access Teva Pharmaceuticals’ Digihaler® family of inhalers ... | June 6, 2023
June 5, 2023
/PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that post-hoc data from two Phase 3 studies of XIAFLEX® (collagenase clostridium...
May 15, 2023
FDA Advisory Committee Votes in Support of Favorable Benefit-Risk Profile for neffy® for the Treatment of Allergic Reactions , Including Anaphylaxis New Drug and Marketing Authorization... | May 15, 2023
May 13, 2023
It was announced by ARS Pharmaceuticals, Inc., that a US Food and Drug Administration Drug Advisory Committee voted in favor of a new intranasal epinephrine treatment for severe allergic reactions.
March 23, 2023
New Drug Application and Marketing Authorization Application for neffy® Currently Under Review with the FDA and EMA; FDA PDUFA Target Action Date Anticipated in Mid-2023 Strong Financial... | March 23, 2023